Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


General Vs. Specific Use Final Guidance Emphasizes FDA Public Health Role

This article was originally published in The Gray Sheet

Executive Summary

FDA re-emphasizes its role as a guardian of public health by strengthening language in the final version of its "Guidance for Industry on General/Specific Intended Use," leaving the door open for reviewers to consider public health issues in deciding when a specific use of a device is covered by a general claim.

You may also be interested in...

FDA/Cryogen Labeling Dispute Attracts Congressional Interest

The House Commerce Committee has asked FDA Commissioner Jane Henney to review the agency's decision requiring Cryogen to submit a premarket approval application to expand the labeling of its First Option intrauterine cryosurgical probe to include specific references to endometrial ablation.

ASH 2020: J&J/Legend’s Cilta-Cel Shines, But BMS/Bluebird’s Ide-Cel Is In First Place

Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts